Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Proceedings of the International Conference on Modern Medicine and Global Health (ICMMGH 2023)
Series Vol. 6 , 03 August 2023
Open
Access | Article
Comparison different stages of treatment mechanism and significance of mitral regurgitation in human and canine heart
* Author to whom correspondence should be addressed.
Abstract
Both humans and dogs have a high incidence of mitral regurgitation with increasing age. Nowadays, because of the improvement of life quality, people pay more attention to the health of themselves and their pets and pursue a higher and better life. This paper mainly introduces the comparison of mitral regurgitation between human and canine. MR Can be divided into acute bicuspid insufficiency and chronic mitral insufficiency according to the progression of the disease. Acute mitral insufficiency: mild cases can only slight labor dyspnea, severe cases can quickly develop acute left heart failure, even acute pulmonary edema, cardiogenic shock. Chronic mitral insufficiency. The degree of clinical symptoms experienced by patients with chronic mitral insufficiency is influenced by the degree of mitral regurgitation, the rate at which the condition progresses, the amount of left atrial and pulmonary venous pressure, and other factors, the level of pulmonary artery pressure, and the combination of other membrane damage and coronary artery disease. Heart structure, routine interventions, diagnosis, treatment, and MR Phases were analyzed. Through comparative analysis, this paper can better let people understand and pay attention to the disease of mitral regurgitation in dogs.
Keywords
canine, mitral regurgitation, surgery, medicine
References
1. Ho S Y. Anatomy of the mitral valve[J]. Heart, 2002, 88(suppl 4): iv5-iv10.
2. Carabello B A. The current therapy for mitral regurgitation[J]. Journal of the American College of Cardiology, 2008, 52(5): 319-326.
3. Borg A N, Pearce K A, Williams S G, et al. Left atrial function and deformation in chronic primary mitral regurgitation[J]. European Journal of Echocardiography, 2009, 10(7): 833-840.
4. Stepien R L, Rak M B, Blume L M. Use of radiographic measurements to diagnose stage B2 preclinical myxomatous mitral valve disease in dogs[J]. Journal of the American Veterinary Medical Association, 2020, 256(10): 1129-1136.
5. Levine R A, Triulzi M O, Harrigan P, et al. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse[J]. Circulation, 1987, 75(4): 756-767.
6. Keene B W, Atkins C E, Bonagura J D, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs[J]. Journal of veterinary internal medicine, 2019, 33(3): 1127-1140.
7. Uechi M. Mitral valve repair in dogs[J]. Journal of Veterinary Cardiology, 2012, 14(1): 185-192.
8. Kanemoto I, Mihara K, Sato K. Open-heart techniques and mitral valve plasty for mitral regurgitation in toy-and small-breed dogs: A review[J]. Open Veterinary Journal, 2021, 11(1): 14-26.
9. Kaul S, Spotnitz W D, Glasheen W P, et al. Mechanism of ischemic mitral regurgitation. An experimental evaluation[J]. Circulation, 1991, 84(5): 2167-2180.
10. Bernay F, Bland J M, Häggström J, et al. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease[J]. Journal of veterinary internal medicine, 2010, 24(2): 331-341
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the International Conference on Modern Medicine and Global Health (ICMMGH 2023)
- ISBN (Print)
- 978-1-915371-65-2
- ISBN (Online)
- 978-1-915371-66-9
- Published Date
- 03 August 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/6/20230315
- Copyright
- © 2023 The Author(s)
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited